Revlimid for treating multiple myeloma, get applied to medical insurance benefit
People are paying attention to the effect of Revlimid, to which Ministry of Health and Welfare applied Risk-sharing contract. Celgene expects to establish a new treatment mechanism for multiple myeloma, and expand its indication in domestic.
Celgene Korea prepared the place to share latest treat...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
